Viewing nowCosarotan 50 mg (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Iksoo Pharmaceutical Co., Ltd.

MFDS item code 201601512 · Approved 2016.03.15 · Insurance code 658501910
Treatment of hypertension and nephropathy in patients with type 2 diabetes accompanied by hypertension
This medication is used to effectively lower the blood pressure of patients with hypertension. It is particularly helpful in protecting the kidney function of patients who suffer from hypertension along with type 2 diabetes. This helps to slow down the progression of kidney disease and improves overall health. Therefore, it is used for the treatment of kidney disease caused by hypertension and diabetes.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension Adults The recommended initial and maintenance dose is losartan potassium 50 mg orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses per day, or the dose may be increased to 100 mg once daily if necessary. If blood pressure is not controlled with this medicine alone, it may be used in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of an excessive decrease in blood pressure. This medicine may be administered concomitantly with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations Elderly patients No adjustment of the initial dose is necessary in patients aged 75 years or younger. For patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Patients with renal impairment Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients receiving dialysis: An initial dose of 25 mg of this medicine once daily is recommended. Patients with reduced intravascular effective blood volume An initial dose of 25 mg of this medicine once daily is recommended for patients who may have reduced intravascular effective blood volume (e.g., patients receiving diuretics) (see Precautions for use). Patients with hepatic impairment Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents aged 6 years and older who weigh at least 20 kg and less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily; depending on the patient's blood pressure response, the dose may be increased to a maximum of 50mg once daily. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily; depending on the patient's blood pressure response, the dose may be increased to a maximum of 100 mg once daily. Not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.
This drug can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so women who are pregnant or could become pregnant should not take it. Patients with severely impaired liver or kidney function, those with hereditary angioedema, and those with primary hyperaldosteronism should also not take this drug. Elderly patients or those with hyperkalemia, liver disease, heart disease, or kidney disease should use this drug with caution, and blood pressure, kidney function, and electrolyte status should be monitored frequently during treatment. This drug is generally well tolerated, but side effects such as dizziness, headache, muscle pain, cough, and dyspepsia may occur, and in rare cases, serious adverse reactions such as angioedema, hepatitis, and renal failure may occur. Blood pressure may drop too low or shock symptoms may appear, so the patient's condition should be closely monitored at the start of treatment or when increasing the dose. This drug can cause a dangerous increase in blood potassium levels when taken together with potassium-sparing diuretics or potassium supplements, so coadministration should be avoided. Also, interactions may occur when taken with other antihypertensives, non-steroidal anti-inflammatory drugs (NSAIDs), lithium, etc., so be sure to consult a physician or pharmacist. Newborns exposed to this drug during pregnancy may have issues such as hypotension and reduced kidney function, so careful observation is needed after birth. Breastfeeding women are advised to avoid taking this drug; if it must be taken, breastfeeding should be discontinued. This drug is not used in children, especially those under 6 years old or those with severely impaired kidney function. During this medication, symptoms such as dizziness or drowsiness may occur, so care should be taken when driving or operating machinery. In cases of overdose, hypotension and bradycardia may occur, and immediate medical attention should be sought.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly closed container. It is important to maintain the storage temperature between 1 to 30 degrees Celsius at room temperature. This helps to preserve the drug's effectiveness and prevent degradation.
White oval film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Iksoo Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.